{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:10:37Z","timestamp":1767856237716,"version":"3.49.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.120","type":"journal-article","created":{"date-parts":[[2005,3,7]],"date-time":"2005-03-07T06:04:44Z","timestamp":1110175484000},"page":"120-123","source":"Crossref","is-referenced-by-count":20,"title":["Cyclophosphamide-induced Cardiomyopathy in a Patient with Seminoma and a History of Mediastinal Irradiation"],"prefix":"10.2169","volume":"44","author":[{"given":"Kenjirou","family":"KAMEZAKI","sequence":"first","affiliation":[{"name":"Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"},{"name":"Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"FUKUDA","sequence":"additional","affiliation":[{"name":"Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"},{"name":"Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyoshi","family":"MAKINO","sequence":"additional","affiliation":[{"name":"Internal Medicine, Miyazaki Prefectural Miyazaki Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"HARADA","sequence":"additional","affiliation":[{"name":"Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703623"},{"key":"2","unstructured":"2) Bearman SI, Petersen FB, Schor RA, et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant <B>5<\/B>: 173-177, 1990."},{"issue":"10","key":"3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","volume":"57","year":"1986","ISSN":"https:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"key":"4","unstructured":"4) Goldberg MA, Antin JH, Guinan EC, et al. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood <B>68<\/B>: 1114-1118, 1986."},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703890"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nieto Y, Cagnoni PJ, Bearman SI, Shpall EJ, Matthes S, Jones RB. Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. Biol Blood Marrow Transplant <B>6<\/B>: 198-203, 2000.","DOI":"10.1016\/S1083-8791(00)70043-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med <B>337<\/B>: 242-253, 1997 (Erratum in: N Engl J Med <B>337<\/B>: 1403, 1997).","DOI":"10.1056\/NEJM199707243370406"},{"key":"8","unstructured":"8) antos GW, Sensenbrenner LL, Burke PJ, et al. Marrow transplanation in man following cyclophosphamide. Transplant Proc <B>3<\/B>: 400-404, 1971."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809243391307"},{"key":"10","unstructured":"10) ee CK, Harman GS, Hohl RJ, et al. Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment. Bone Marrow Transplant <B>18<\/B>: 573-577, 1996."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Buja LM, Ferrans VJ, Graw RG Jr. Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol <B>7<\/B>: 17-45, 1976.","DOI":"10.1016\/S0046-8177(76)80004-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Levine ES, Friedman HS, Griffith OW, Colvin OM, Raynor JH, Lieberman M. Cardiac cell toxicity induced by 4-hydroperoxycyclophosphamide is modulated by glutathione. Cardiovasc Res <B>27<\/B>: 1248-1253, 1993.","DOI":"10.1093\/cvr\/27.7.1248"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Birchall IW, Lalani Z, Venner P, et al. Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy. Br J Radiol <B>73<\/B>: 1112-1114, 2000.","DOI":"10.1259\/bjr.73.874.11271907"},{"issue":"5","key":"14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1200\/JCO.1994.12.5.998","volume":"12","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0732-183X","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702466"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/2\/44_2_120\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:23:11Z","timestamp":1621444991000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/2\/44_2_120\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.120","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}